TrialClinical cancer research : an official journal of the American Association for Cancer Research2016

Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma.

Mattias Carlsten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.